From: A metabolome-wide case-control study of african american breast cancer patients
Pathway | m/z | RT (s) | Tentative match | Fold change (log2)a | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Scenario 1b | Scenario 2b | Scenario 3b | Scenario 4b | Scenario 5b | Scenario 6b | Scenario 7b | ||||
Prostaglandin formation from arachidonate | 410.2634 | 12.13 | 12-hydroperoxyeicosatetraenoate glyceryl ester | 3.18 | 2.94 | 3.47 | 3.03 | 3.37 | 2.94 | 3.34 |
424.2432 | 12.27 | 15-oxo-Prostaglandin E2 glyceryl ester | 2.78 | 2.31c | 3.35 | 2.43 | 3.29 | 2.33c | 3.08 | |
368.2161 | 10.16 | 20-dihydroxyleukotriene B4 | 2.33 | 2.12 | 2.57 | 2.13 | 2.61 | 2.27 | 2.36 | |
368.2166 | 10.22 | Prostaglandin G2 | 2.17 | 2.07 | 2.28 | 2.07 | 2.31 | 2.21 | 2.14 | |
366.2008 | 10.24 | 11-dehydro-15-keto-TXB2 | 3.24 | 3.19 | 3.30 | 3.22 | 3.26 | 3.13 | 3.32 | |
352.2236 | 10.93 | Prostaglandin E2 | 2.19 | 1.99 | 2.42 | 1.94c | 2.53 | 1.88c | 2.39 | |
424.2438 | 12.60 | 15-oxo-Prostaglandin E2 glyceryl ester | 2.62 | 2.19 | 3.14 | 2.37 | 3.00 | 2.21 | 2.89 | |
370.2706 | 11.99 | Anandamide | 4.18 | 3.66 | 4.79 | 3.88 | 4.56 | 3.78 | 4.43 | |
366.2008 | 10.20 | 12-oxo-20-dihydroxy-leukotriene B4 | 3.24c | 3.19c | 3.30 | 3.22c | 3.26 | 3.13c | 3.32 | |
 | 368.2161 | 10.16 | 20-dihydroxyleukotriene B4 | 2.33c | 2.12c | 2.57c | 2.13c | 2.61 | 2.27c | 2.36c |
Leukotriene metabolism | 364.1858 | 12.20 | 20-carboxy-leukotriene-B4 | 2.30 | 2.09 | 2.54 | 2.19 | 2.43 | 2.16 | 2.38 |
368.2161 | 10.16 | 20-dihydroxyleukotriene B4 | 2.33 | 2.12 | 2.57 | 2.13 | 2.61 | 2.27 | 2.36 | |
496.2647 | 10.87 | Leukotriene D4 | 2.06 | 1.92 | 2.23 | 2.09 | 1.99 | 2.06 | 2.06 | |
382.1958 | 10.76 | 12-oxo-20-trihydroxy-leukotriene B4 | 3.27 | 2.89c | 3.72 | 3.10 | 3.51 | 3.06c | 3.40 | |
366.2008 | 10.24 | 20-COOH-10,11-dihydro-LTB4 | 3.24 | 3.19 | 3.30 | 3.22 | 3.26 | 3.13c | 3.32 | |
370.1772 | 9.29 | 12,20-dioxo-leukotriene B4 | 3.20 | 2.94 | 3.51 | 2.91 | 3.59 | 2.89 | 3.40 | |
352.2236 | 10.93 | Prostaglandin E2 | 2.19 | 1.99c | 2.42 | 1.94c | 2.53 | 1.88c | 2.39 | |
366.2008 | 10.24 | 11-dihydro-LTB4 | 3.24 | 3.19 | 3.30 | 3.22 | 3.26 | 3.13 | 3.32 | |
 | 630.4014 | 13.93 | Kurilensoside F | 1.18c | 0.97c | 1.43 | 1.29c | 1.05 | 1.21c | 1.16 |
Glycerophospholipid metabolism | 299.2820 | 14.07 | Sphingosine | -1.14 | -1.22 | -1.05 | -1.13 | -1.16 | -1.18 | -1.12 |
687.4946 | 14.68 | Diacylglycerol | -1.91 | -2.09 | -1.69 | -1.87 | -1.96 | -1.81 | -1.96 | |
278.2252 | 16.23 | (6Z,9Z,12Z)-Octadecatrienoic acid | -2.09 | -2.26 | -1.89 | -2.17 | -1.96 | -2.18 | -2.03 | |
301.2975 | 11.47 | Sphinganine | -1.30 | -1.38 | -1.20 | -1.34 | -1.23 | -1.32c | -1.28 | |
280.2400 | 15.23 | Linoleic acid (all cis C18:2) n-6 | -1.72 | -1.92 | -1.48 | -1.75 | -1.68 | -1.74 | -1.71 | |
299.2822 | 11.17 | 3-dehydrosphinganine | -2.26 | -2.39 | -2.09 | -2.29 | -2.19 | -2.25 | -2.26 | |
417.2354 | 11.59 | 1-(1-Alkenyl)-sn-glycero-3-phosphate | -1.67c | -1.40c | -2.00 | -1.50 | -1.91 | -1.57c | -1.74 |